Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Flufenazin
2. Fluphenazine
3. Hydrochloride, Fluphenazine
4. Lyogen
5. Prolixin
1. Fluphenazine Dihydrochloride
2. 146-56-5
3. Prolixin
4. Anatensol
5. Permitil
6. Fluphenazine (dihydrochloride)
7. Tensofin
8. Moditen
9. Squibb 4918
10. Dapotum
11. Omca
12. Fluphenazine Hcl
13. Calmansial
14. Flufenazin
15. Lyorodin
16. Liogen
17. Fluphenazine Chloride
18. Fluphenazine Dihcl
19. Fluorophenazine Dihydrochloride
20. Zou145w1xl
21. Valamina
22. 1-(2-hydroxyethyl)-4-(3-(2-trifluoromethyl-10-phenothiazinylpropyl)piperazine Dihydrochloride
23. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)-, Dihydrochloride
24. 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazineethanol Dihydrochloride
25. Nsc-179197
26. Trancin
27. A 4077
28. 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride
29. Permitil Hydrochloride
30. 10-(3-(4-(2-hydroxyethyl)piperazinyl)propyl)-2-trifluoromethylphenothiazine Dihydrochloride
31. 1-piperazineethanol, 4-[3-[2-(trifluoromethyl)-10h-phenothiazin-10-yl]propyl]-, Dihydrochloride
32. 2-(4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol Dihydrochloride
33. Ccris 4032
34. Nsc 62323
35. Sr-01000003048
36. Einecs 205-674-1
37. Unii-zou145w1xl
38. Nsc 179197
39. Siqualone
40. Fluphenazine 2hcl
41. Prolixin (tn)
42. 2-(4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)piperazin-1-yl)ethan-1-ol Dihydrochloride
43. 2-(4-{3-[2-(trifluoromethyl)-10h-phenothiazin-10-yl]propyl}piperazin-1-yl)ethan-1-ol Dihydrochloride
44. Prestwick_225
45. Fluphenazine Hydrochloride [usp:ban:jan]
46. Schembl41634
47. Spectrum1500994
48. Chebi:5126
49. Flufenazine Hydrochloride
50. Chembl1448187
51. Dtxsid00892922
52. Hms1568p22
53. Hms1921o14
54. Bcp18079
55. Hy-a0081
56. Tox21_500555
57. S4569
58. Fluphenazine Hydrochloride (jan/usp)
59. Akos015960787
60. Ccg-212902
61. Cs-4290
62. Lp00555
63. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-, Dihydrochloride
64. Fluphenazine Hydrochloride [jan]
65. Fluphenazine Dihydrochloride [mi]
66. Ncgc00093941-01
67. Ncgc00093941-02
68. Ncgc00093941-03
69. Ncgc00261240-01
70. Ac-12201
71. Bs-15804
72. Fluphenazine Hydrochloride [mart.]
73. Fluphenazine Hydrochloride [vandf]
74. S4569 Fluphenazine (dihydrochloride).cd
75. Fluphenazine Hydrochloride [usp-rs]
76. Fluphenazine Hydrochloride [who-dd]
77. Fluphenazine Hydrochloride [who-ip]
78. Eu-0100555
79. F1240
80. Ft-0668755
81. C72785
82. D00791
83. F 4765
84. Fluphenazine Hydrochloride [orange Book]
85. Fluphenazine Hydrochloride [usp Impurity]
86. Fluphenazine Hydrochloride [usp Monograph]
87. Fluphenazini Hydrochloridum [who-ip Latin]
88. Sr-01000003048-2
89. Sr-01000003048-9
90. W-108125
91. Fluphenazine Dihydrochloride 100 Microg/ml In Methanol
92. Q27295826
93. Z2784093501
94. Fluphenazine Dihydrochloride 1.0 Mg/ml In Methanol (as Free Base)
95. Fluphenazine Dihydrochloride, European Pharmacopoeia (ep) Reference Standard
96. Fluphenazine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
97. Fluphenazine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
98. 2-(4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanoldihydrochloride
99. 2-(4-{3-[2-(trifluoromethyl)-10h-phenothiazin-10-yl]propyl}-1-piperazinyl)ethanol Dihydrochloride
100. 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol,dihydrochloride
101. Fluphenazine Dihydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
| Molecular Weight | 510.4 g/mol |
|---|---|
| Molecular Formula | C22H28Cl2F3N3OS |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | 509.1282236 g/mol |
| Monoisotopic Mass | 509.1282236 g/mol |
| Topological Polar Surface Area | 55.2 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 544 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | Fluphenazine hydrochloride |
| PubMed Health | Fluphenazine Hydrochloride (By mouth) |
| Drug Classes | Analgesic, Antipsychotic |
| Drug Label | Fluphenazine hydrochloride is a trifluoromethyl phenothiazine derivative intended for the management of schizophrenia. Chemically it is 4-[3-[2-(Trifluoromethyl) phenothiazin-10-yl]propyl]-1-piperazineethanol dihydrochloride which may be represented... |
| Active Ingredient | Fluphenazine hydrochloride |
| Dosage Form | Elixir; Tablet; Concentrate; Injectable |
| Route | Injection; Oral |
| Strength | 2.5mg; 1mg; 2.5mg/ml; 2.5mg/5ml; 5mg; 5mg/ml; 10mg |
| Market Status | Prescription |
| Company | Pharm Assoc; Sandoz; Fresenius Kabi Usa; Lannett; Mylan |
| 2 of 2 | |
|---|---|
| Drug Name | Fluphenazine hydrochloride |
| PubMed Health | Fluphenazine Hydrochloride (By mouth) |
| Drug Classes | Analgesic, Antipsychotic |
| Drug Label | Fluphenazine hydrochloride is a trifluoromethyl phenothiazine derivative intended for the management of schizophrenia. Chemically it is 4-[3-[2-(Trifluoromethyl) phenothiazin-10-yl]propyl]-1-piperazineethanol dihydrochloride which may be represented... |
| Active Ingredient | Fluphenazine hydrochloride |
| Dosage Form | Elixir; Tablet; Concentrate; Injectable |
| Route | Injection; Oral |
| Strength | 2.5mg; 1mg; 2.5mg/ml; 2.5mg/5ml; 5mg; 5mg/ml; 10mg |
| Market Status | Prescription |
| Company | Pharm Assoc; Sandoz; Fresenius Kabi Usa; Lannett; Mylan |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seqens
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Controlled & Modified Release
Direct Compression
Thickeners and Stabilizers
Solubilizers
Parenteral
Granulation
Lubricants & Glidants
Co-Processed Excipients
Topical
Film Formers & Plasticizers
Disintegrants & Superdisintegrants
Taste Masking
Emulsifying Agents
Chewable & Orodispersible Aids
Empty Capsules
Vegetarian Capsules
API Stability Enhancers
Coloring Agents
Surfactant & Foaming Agents
Rheology Modifiers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Fluphenazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fluphenazine, including repackagers and relabelers. The FDA regulates Fluphenazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fluphenazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fluphenazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fluphenazine supplier is an individual or a company that provides Fluphenazine active pharmaceutical ingredient (API) or Fluphenazine finished formulations upon request. The Fluphenazine suppliers may include Fluphenazine API manufacturers, exporters, distributors and traders.
click here to find a list of Fluphenazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fluphenazine DMF (Drug Master File) is a document detailing the whole manufacturing process of Fluphenazine active pharmaceutical ingredient (API) in detail. Different forms of Fluphenazine DMFs exist exist since differing nations have different regulations, such as Fluphenazine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fluphenazine DMF submitted to regulatory agencies in the US is known as a USDMF. Fluphenazine USDMF includes data on Fluphenazine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fluphenazine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fluphenazine suppliers with USDMF on PharmaCompass.
A Fluphenazine CEP of the European Pharmacopoeia monograph is often referred to as a Fluphenazine Certificate of Suitability (COS). The purpose of a Fluphenazine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fluphenazine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fluphenazine to their clients by showing that a Fluphenazine CEP has been issued for it. The manufacturer submits a Fluphenazine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fluphenazine CEP holder for the record. Additionally, the data presented in the Fluphenazine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fluphenazine DMF.
A Fluphenazine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fluphenazine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fluphenazine suppliers with CEP (COS) on PharmaCompass.
A Fluphenazine written confirmation (Fluphenazine WC) is an official document issued by a regulatory agency to a Fluphenazine manufacturer, verifying that the manufacturing facility of a Fluphenazine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fluphenazine APIs or Fluphenazine finished pharmaceutical products to another nation, regulatory agencies frequently require a Fluphenazine WC (written confirmation) as part of the regulatory process.
click here to find a list of Fluphenazine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fluphenazine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fluphenazine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fluphenazine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fluphenazine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fluphenazine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fluphenazine suppliers with NDC on PharmaCompass.
Fluphenazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fluphenazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fluphenazine GMP manufacturer or Fluphenazine GMP API supplier for your needs.
A Fluphenazine CoA (Certificate of Analysis) is a formal document that attests to Fluphenazine's compliance with Fluphenazine specifications and serves as a tool for batch-level quality control.
Fluphenazine CoA mostly includes findings from lab analyses of a specific batch. For each Fluphenazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fluphenazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Fluphenazine EP), Fluphenazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fluphenazine USP).
LOOKING FOR A SUPPLIER?
